Atherosclerotic lesions have been reported to contain herpes simplex virus 1 (HSV-1) genomic material. This, and other previous evidence, suggests that latent viral infection may be an atherogenic trigger. Moreover, active HSV-1 lesions manifest marked fibrin deposition in microvessels. In this report we show that very early infection of human endothelial cells with HSV-1 appears to alter surface conformation as detected by merocyanine 540 staining. Concomitantly, the efficiency of prothrombinase complex assembly increases, resulting in a 2-to 3-fold accelerated rate of thrombin generation on the cell surface. Increased thrombin generation is probably doubly procoagulant, since we also demonstrate that thrombin-induced platelet accumulation on HSV-infected endothellum (50.7 ± 9.3%) is increased compared to uninfected endothelium (9.5 ± 2.1%; P < 0.002). Associated with HSV infection, prostacyclin secretion in response to thrombin is diminished by a factor of 20, probably explaining the enhanced platelet attachment. We conclude that HSV infection shifts endothelial cell properties from anticoagulant to procoagulant, both by promoting prothrombinase complex formation and function and by increasing platelet binding, well before cell disruption takes place. Virus-induced changes in the endothellal plasma membrane and diminished prostacyclin secretion are suggested as the pathways for this pathophysiologic mechanism, which may be germane to atherosclerotic thrombosis as well as HSV-mediated tissue necrosis.An intact vascular endothelium is actively antithrombotic. Rather than forming a passive vascular lining, endothelium has a variety of natural anticoagulant properties that are able to exert a dampening effect upon the coagulation cascade (1, 2): heparin-like species, thrombomodulin, plasminogen activator, and prostacyclin are endothelial constituents thought to contribute to vascular thromboresistance. Consequently, a breach of this barrier by mechanical disruption of the endothelial lining with frank endothelial loss and exposure of the subendothelium can lead to massive coagulation activation and platelet adherence. More subtle injury to endothehum that might alter its thromboresistant properties has only recently emerged as a topic of inquiry (3). Theoretically, several different mechanisms may be involved in diminished endothelial thromboresistance: (i) decreased production or exhibition of the above-mentioned antithrombotic factors; (ii) increased production or secretion ofthrombogenic factors such as tissue factor, platelet-activating factor, von Willebrand factor, and plasminogen-activator inhibitor; and (iii) changes in the endothelial cell surface, leading to altered exposure of proteins or procoagulant phospholipids.With regard to mechanism iii, endothelial cell surface alterations can result from viral infection, which readily occurs with several viruses in vitro. Diverse viruses replicate readily in cultured endothelium, including herpesviruses, adenoviruses, and enteroviruses, among others (4,...